Achaogen Stock

Achaogen FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Achaogen (AKAOQ) as of Aug 13, 2026 is 93.31 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 81.49 % — a change of 14.51% (higher).

FCF Conversion

93.31 %

YoY

14.51%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Achaogen is 2026 93.31 % . FCF Conversion Rate (FCF/EBITDA) of Achaogen was 2025 81.49 % . It decreases by 14.51% higher compared to the previous year.
Access this data via the Eulerpool API

Achaogen Stock analysis

What does Achaogen do? Achaogen Inc is an innovative biotechnology company specializing in the development of antibiotics for the treatment of life-threatening infectious diseases. The company's business model is based on research and development of new antibiotics, aiming to improve medical care for patients with infections. Achaogen was founded in 2002 by a team of researchers and professionals in the biotechnology industry and has developed several products for the treatment of diseases such as pneumonia, urinary tract infections, and bloodstream infections. The company's main divisions include Plazomicin, Zemdri, and C-Scape, which are antibiotics targeting different types of infections. Achaogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Achaogen stock

FCF Conversion Rate (FCF/EBITDA) of Achaogen is 93.31 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Achaogen changed from 81.49 % to 93.31 %, representing a 14.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Achaogen since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Achaogen with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Achaogen

All Key Metrics — Achaogen